tbuckley/cabot-search huggingface dataset:
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS): An international, multicentre, randomised pragmatic trial
Authors: K.A.O. Tikkinen, V. Kasivisvanathan, S.V. Tornberg, S. Hajebrahimi, P.D. Violette, K-M. Kaukonen, V. Sallinen, A. Agarwal, R. Cartwright, L.I. Lavikainen, R.M. Tähtinen, A. Ng, A. Nathan, T.P. Kilpeläinen, K. Keane, S. Ippoliti, A. Asif, K. Ahopelto, R.L. Aaltonen, P.M. Sandset, P.L. Gross, S. Parpia, G.H. Guyatt, P.J. Devereaux
Journal: European Urology (2024)
Should patients with PIRADS 5 lesions be recommended against active surveillance? A multicenter retrospective European study
Authors: A. Peyrottes, Q. Ducrot, C. Vitard, A. Baudewyns, O. Windisch, J. Anract, C. Dariane, T. Tricard, M. Baboudjian, J. Sarkis, Y. Sadreux, M. Oderda, A. De La Taille, J. Olivier, L. Brureau, R. Diamand, O. Rouviere, A. Ruffion, F. Desgrandchamps, M. Roumiguie, G. Ploussard, G. Fiard
Journal: European Urology (2024)
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy
Authors: C. Siech, R.B. Incesu, S. Morra, L. Scheipner, A. Baudo, L.M.I. Jannello, M. de Angelis, J.A. Goyal, Z. Tian, F. Saad, S.F. Shariat, D. Tilki, N. Longo, L. Carmignani, O. De Cobelli, S. Ahyai, A. Briganti, P. Mandel, L.A. Kluth, F.K.H. Chun, P.I. Karakiewicz
Journal: European Urology (2024)
Platelet RNAs as potential biomarkers in prostate cancer detection: Highlighting differential expression of hsa-miR-627, hsa-miR-22, and hsa-miR-190
Authors: X.K. Wang, T.Y. Guo, J.Y. Gu, E. Burke, C.R. Davies, N.H. Feng, Y-J. Lu
Journal: European Urology (2024)
Tumor size predicts survival for urachal cancer – findings from a nationwide multicenter cohort study in Norway
Authors: S.N. Akhtar, E.S. Haug, B. Carlsen, E.J. Aarsaether, A-K. Karlsvik, E. Kjoebli, I. Hannestad, S. Müller, O.A. Hopland, M. Dimmen, P. Juliebø-Jones, C. Beisland, G. Gudbrandsdottir
Journal: European Urology (2024)
PSICHE trial (NCT05022914): PSMA guided approach for bIochemical relapse after prostatectomy- a prospective trial
Authors: G. Francolini, V. Di Cataldo, P. Garlatti, B. Detti, N. Bertini, B. Ilaria, S. Caini, C. Franzese, M. Scorsetti, N. Simoni, F. Colombo, A. Chiti, S. Serni, R. Campi, A. Minervini, L. Vaggelli, L. Burchini, G. Frosini, M. Loi, G. Simontacchi, I. Desideri, I. Meattini, R.K. Valicenti, L. Livi
Journal: European Urology (2024)
A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series
Authors: A. Stabile, R. Leni, L. Quarta, E. Mazzone, D. Cannoletta, G. Gandaglia, F. Pellegrino, G. Sorce, A. Pellegrino, T. Russo, M. Cosenza, R. Pennella, G. Brembilla, F. De Cobelli, V. Cucchiara, S. Scuderi, D. Robesti, R.J. Karnes, M. Roupret, F. Montorsi, A. Briganti
Journal: European Urology (2024)
MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score
Authors: N. Sushentsev, M. Wiesenfarth, M. Dixius, C. Kastner, A. Borkowetz, I. Platzek, C. Thomas, C. Kesch, L. Umutlu, H. Reis, T. Rau, L. Lenders, M. Spahn, M. Boschheidgen, G. Antoch, P. Albers, T. Barrett, L. Schimmöller, B. Hadaschik, J.P. Radtke
Journal: European Urology (2024)
Preoperative MRI to assess the anatomical location of positive surgical margin at Robot-Assisted Radical Prostatectomy (RARP)
Authors: S.H. van der Graaf, V. Sweere, H. Veerman, T.N. Boellaard, I.G. Schoots, E.M.K. Wit, T.A. Roeleveld, J.A. Nieuwenhuijzen, A.N. Vis, H.P. Beerlage, H.G. Van Der Poel, P.J. Van Leeuwen
Journal: European Urology (2024)
PROSPET-BX trial: [G8Ga]PSMA PET/CT vs. mpMRI in patients with suspicion of prostate cancer and previous negative biopsy
Authors: D. Maffei, G. Lughezzani, M. Lazzeri, V. Fasulo, P. Arena, L. Disconzi, P. Colombo, A. Saita, R.F. Hurle, G.F. Guazzoni, L. Balzarini, M. Rodari, P. Casale, N.M. Buffi, E. Lopci
Journal: European Urology (2024)
Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination
Authors: C. Aydogdu, P. Paffenholz, R. Stelmach, K. Schlack, F. Roghmann, A. Handke, S. Mandal, M. Schnabel, A. Merseburger, P. Ivanyi, S. Tschäbitz, C. Darr, V. Grünwald, C.G. Stief, J. Casuscelli
Journal: European Urology (2024)
Time to death and clinical characteristics of patients who died for prostate cancer after robot-assisted radical prostatectomy: 20 years’ report from the EAU Robotic Urology Section (ERUS) scientific working group
Authors: U.G. Falagario, F. Pellegrino, M.C. Moschovas, S. Knipper, A. Martini, O. Akre, L. Egevad, M. Aly, C.A. Bravi, J. Tran, Y. Heiniger, A. Von Kempis, R. Schaffar, G. Carrieri, A. Briganti, F. Montorsi, C-H. Rochat, A. Mottrie, T.E. Ahlering, H. John, V. Patel, M. Graefen, P. Wiklund
Journal: European Urology (2024)
Outcome of patients with synchronous metastatic renal cell carcinoma treated with nivolumab and ipilimumab and the primary tumour in place
Authors: L. Jurascheck, E. Fransen Van De Putte, L. Van Den Brink, J.C. Van Der Mijn, S. Wilgenhof, J.V. Van Thienen, J.B.A.G. Haanen, E. Boleti, T. Powles, P.J. Zondervan, N.M. Graafland, A. Bex
Journal: European Urology (2024)
Neoadjuvant PD-1 inhibitor plus etoposide and cisplatin in neuroendocrine bladder carcinoma: a single-center, real-world study
Authors: H. Chen, Q. Lei, Z. Tianxiang, Z. Ruiyun, J. Di, X. Jun, W. Guangyu, C. Ming, Z. Lianhua
Journal: European Urology (2024)
PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy
Authors: L. Nocera, E. Mazzone, S. Scuderi, F. Barletta, D. Cannoletta, L. Quarta, A. Pellegrino, F. Pellegrino, P. Scilipoti, G. Sorce, R. Leni, M. Longoni, G.O. Cirulli, V. Cucchiara, D. Robesti, G. Gandaglia, F. Montorsi, A. Briganti
Journal: European Urology (2024)
High androgen expression is linked to poor prognosis in male patients with muscle-invasive urothelial carcinoma of the bladder
Authors: H. Plage, S. Hofbauer, K. Furlano, F. Roßner, S. Schallenberg, S. Elezkurtaj, M. Kluth, M. Lennartz, A.H. Marx, H. Samtleben, M. Fisch, M. Rink, M. Slojewski, K. Kaczmarek, T. Klatte, S. Koch, E. Burandt, S. Minner, R. Simon, G. Sauter, H. Zecha, T. Schlomm, T. Ecke
Journal: European Urology (2024)
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review, meta-analysis, and network meta-analysis
Authors: A. Matsukawa, P. Rajwa, B. Kensuke, E. Laukhtina, J. Klemm, B. Pradere, K. Mori, P. Karakiewicz, T. Kimura, P. Chlosta, S. Shariat, T. Yanagisawa
Journal: European Urology (2024)
3D augmented reality robot-assisted segmental ureterectomy with buccal mucosa graft repair: Technique description and short-term outcomes
Authors: F. Piramide, A. Piana, D. Amparore, M. Manfredi, E. Checcucci, P. Alessio, S.T. De Cillis, G. Volpi, M. Sica, P. Verri, M. Burgio, J. Meziere, A. Quara’, E. Cisero, G. Busacca, L. Marsero, M. Colombo, A.G. Mesterca, A. Sterrantino, B.S. Ribolzi, M. Di Dio, C. Fiori, F. Porpiglia
Journal: European Urology (2024)
Implementation of robot-assisted kidney transplantation in surgical practice at referral European transplant Centres: An audit within the ERUS-RAKT working group
Authors: A. Pecoraro, R. Campi, A. Gallioli, A. Territo, G. Basile, J.M. Gaya, B. Etcheverry, G. Vignolini, T. Prudhomme, M. Ortved, P. Zeuschner, R. Garcia-Baquero, P. Fornara, M. Rohrsted, N. Doumerc, S. Serni, A. Breda
Journal: European Urology (2024)
Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer
Authors: L. Emmett, N. Papa, T. Hope, W. Fendler, J. Calais, I. Burger, M. Eiber, F. Barbato, D. Moon, A. Xue, A. Franklin, J. Thompson, K. Rasiah, M. Frydenberg, J. Yaxley, J. Buteau, V. Liu, A. Nguyen, E. Hsiao, P. Stricker, M. Hofman, V. Kasivisvanathan, M. Roberts, D. Murphy
Journal: European Urology (2024)
The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office
Authors: W. Devlies, J.J.D. Jong, F. Hofmann, H.M. Bruins, T.C.M. Zuiverloon, E.J. Smith, Y. Yuan, B.W.G. Van Rhijn, H. Mostafid, N. Santesso, P. Violette, M.I. Omar
Journal: European Urology (2024)
Clinical Application of Bladder MRI and Vesical Imaging-Reporting And Data System
Authors: V. Panebianco, A. Briganti, T.N. Boellaard, J. Catto, E. Compera, J. Efstathiou, A.G. Van Der Heijden, G. Giannarini, R. Girometti, L. Mertens, M. Takeuchi, V.F. Muglia, Y. Narumi, G. Novara, M. Pecoraro, M. Roupret, F. Sanguedolce, D. Santini, S.F. Shariat, G. Simone, H.A. Vargas, S. Woo, J.O. Barentsz, J.A. Witjes
Journal: European Urology (2024)
Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer
Authors: G.T. Devos, L. Tosco, M. Baldewijns, A. Giesen, T. Gevaert, K. Goffin, V. Petit, C. Mai, Y. Raskin, C. Van Haute, G. De Meerleer, C. Berghen, W. Devlies, H. Van Poppel, F. Claessens, W. Everaerts, S. Joniau
Journal: European Urology (2024)
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin ineligible muscle invasive bladder cancer
Authors: R. Satkunasivam, B.S. Teh, C. Riveros, K. Lim, C.J.D. Wallis, S. Hu, Z. Melchiode, F. Nikolos, B.J. Miles, D. Kaushik, S.H. Chen, E. Efstathiou, K.S. Chan, N.F. Esnaola, G.P. Sonpavde
Journal: European Urology (2024)
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort
Authors: G.O. Cirulli, M. Finati, G. Chiarelli, A. Stephens, M. Davis, S. Tinsley, C. Morrison, S. Arora, M. Butaney, A. Sood, G. Lughezzani, N. Buffi, G. Carrieri, A. Salonia, A. Briganti, F. Montorsi, C. Rogers, F. Abdollah
Journal: European Urology (2024)
Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer
Authors: R. Weiten, M. Niemann, E. Below, L.L. Friker, D.J. Ralser, M. Toma, G. Kristiansen, O. Hahn, S. Zechel, V. Grünwald, T. Bald, J. Siewert, T. Pietsch, M. Ritter, M. Hölzel, M. Eckstein, A. Alajati, P. Krausewitz, N. Klümper
Journal: European Urology (2024)
Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)
Authors: C. Mercinelli, D. Raggi, A. Cigliola, V. Tateo, D.A. Patanè, E. Crupi, M. Colecchia, M. Moschini, C. Re, G. Avesani, A. Briganti, F. Montorsi, J.S. Ross, R. Graf, D.C. Pavllick, A. Necchi
Journal: European Urology (2024)
POPCORN study: Application of the “One-Step Nucleic Acid amplification” (OSNA) method for the detection of nodal metastasis in patients with prostate cancer
Authors: M. Cuadras Sole, M.E. Semidey, I.S.M. de Torres, J. Planas, R. Medina, D. Marcilla, L. Martínez-Pineiro, P. González-Peramato, A. Leivar, C. Carrato, J. Areal, P.L. Fernández, M. Ramírez, A. Calatrava, D.O. Vázquez-Martul, F. Queipo, J. Moreno, R. Luque, J.L. Álvarez, I. Catalina, S. Ramón Y Cajal, E. Trilla, J. Morote
Journal: European Urology (2024)
Long-term sexual health of men on active surveillance for low-risk prostate cancer – results of the Movember GAP3 consortium
Authors: L.D.F. Venderbos, D. Nieboer, J. Helleman, M. Peacock, M. Van Hemelrijck, C. Pavlovich, P. Carroll, M.J. Roobol
Journal: European Urology (2024)
Prognostic factors for Overall Survival (OS) in patients receiving First-line (1L) Nivolumab plus Ipilimumab (NIVO+IPI) for advanced/metastatic Renal Cell Carcinoma (aRCC) in a real-world setting in Germany
Authors: J. Bedke, V. Grünwald, H. Müller-Huesmann, H. Belz, E. Von Der Heyde, M. Bögemann, A. Strauß, L. Vaz, T. Bluhmki, M. Herber, S. Groetzinger, M-O. Grimm
Journal: European Urology (2024)
Systematic review of clinical outcomes and step-by-step description of orthotopic bladder reconstruction following robot-assisted radical cystectomy
Authors: F. Piramide, F. Turri, D. Amparore, G. Fallara, R. De Groote, C. Wuernschimmel, F. Di Maida, N. Liakos, F. Pellegrino, I. Andras, A. Mastrorosa, R. Bianchi, A. Galfano, A. Minervini, G. Simone, A. Briganti, O. De Cobelli, R. Gaston, F. Montorsi, P. Wiklund, F. Porpiglia, A. Mottrie, A. Larcher, P. Dell’Oglio
Journal: European Urology (2024)
Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric MRI (PIRADS/Likert 3-5) and negative initial biopsy. A systematic review
Authors: N. Grivas, M. Lardas, E. Linares Espinós, T. Lam, O. Rouviere, N. Mottet, R. Van Den Bergh, D. Tilki, P. Cornford
Journal: European Urology (2024)
Delayed nephrectomy after immunotherapy for metastatic renal cell carcinoma: Oncological outcomes and predictive factors of surgical difficulties
Authors: G. Pignot, G. Margue, P. Bigot, H. Lang, L. Balssa, G. Roubaud, D. Borchiellini, K. Bensalah, F. Schlürmann, S. Ladoire, B. Parier, J.C. Bernhard, O. Cassuto, L. Albiges, C. Thibault, A. Ingels, F. Cherifi, T. Waeckel, J. Walz, R. Flippot, L. Geoffrois, G. Gravis, P. Barthelemy
Journal: European Urology (2024)
SunRISe-3: TAR-200 plus cetrelimab or TAR-200 versus intravesical Bacillus Calmette–Guérin in patients with BCG-naive high-risk non–muscle-invasive bladder cancer
Authors: J.W.F. Catto, A. Necchi, T. Powles, F. Guerrero-Ramos, G. Simone, N. Shore, J.S. Salinas, A.S. Merseburger, M. Roumiguie, K. Hiroshi, D.M. Morris, W. Qiang, F. Korkes, M. Hasan, S. Jin, J. Maffeo, C. Hammond, H. Sweiti, R.S. Somer, S.S. Chang
Journal: European Urology (2024)
Prognostic factors of long-term survival rates after PSMA/PET-based salvage whole pelvic radiotherapy for recurrent prostate cancer
Authors: N. Grivas, L. Zuur, P. Van Leeuwen, E. Wit, A. Vis, J. Nieuwenhuijzen, W. Vogel, F. Pos, H. Van Der Poel
Journal: European Urology (2024)
Development of prostate cancer typical case presentations and their usage in OPTIMA’s guideline based decision support tool
Authors: C. Murray, K. Beyer, G. Gandaglia, A. Stabile, S. Auweter, A. Morariu, I. Santiago, S. Maclennan, S. Maclennan, M. Thomas, A. Bjartell, P. Cornford, H. Kruger, J. N’dow, M. Roobol, M.I. Omar
Journal: European Urology (2024)
Kidney transplant in patients with unique blood transfusion preferences: A study of ethical and clinical aspects at a specialized institution
Authors: N. García Formoso, E. Herrero Blanco, E. Alonso Mediavilla, R. Ballestero Diego, F. Campos Juanatey, G. Velilla Díez, J. García Herrero, M. Sánchez Gil, G. Azcárraga Aranegui, M.Á. Latatu Córdoba, E. Expósito Ibánez, M. Domínguez Esteban, S. Zubillaga Guerrero, J.L. Gutiérrez Banos
Journal: European Urology (2024)
Metformin - a risk factor for metabolic acidosis after radical cystectomy with ileal conduit or continent diversion? A national claims database analysis
Authors: M. Pallauf, M. Rezaee, T.P. Kohn, M. Mcnamara, S. Broenimann, J. Hoffman-Censits, A. Smith, N. Singla
Journal: European Urology (2024)
Who’s at risk? New postoperative hydronephrosis in ureteroscopy patients without prior hydronephrosis
Authors: G. Fernandez Moncaleano, R.E.N. Becker, S. Meah, S. Daignault-Newton, J.M. Thelus, J. Ross, R. Sarle, D. Wenzler, B. Seifman, K.R. Ghani, C.A. Dauw
Journal: European Urology (2024)
Single-cell RNA-seq analysis reveals the role of tumor-associated neutrophils and neutrophil extracellular traps in upper tract urothelial carcinoma
Authors: Y. Wang, X.E. Shen, D. Gu, Y.F. Shen, L.J. Fan, J. Ruan, P. Zhao, M.Z. Li, Y.T. Huang, X.Z. Long
Journal: European Urology (2024)
Effect of prior focal therapy vs. radiation on the outcomes of salvage robotic radical prostatectomy
Authors: A. Ghoreifi, L. Storino Ramacciotti, M. Kaneko, G.E. Cacciamani, H. Djaladat, R. Sotelo, M. Desai, I. Gill, M. Aron, A.L. Abreu
Journal: European Urology (2024)
A novel approach to identify aggressive prostate cancer via DNA-methylation signatures from prostate needle biopsy
Authors: M. Kaneko, Y. Sekino, H. Li, X. Zhou, M. Jin, W. Guo, X. Yang, J. Bhasin, A. Fujihara, T. Iwata, L.S. Ramacciotti, D. Paralkar, G.E. Cacciamani, M. Aron, O. Ukimura, I.S. Gill, G. Liang, A.L. Abreu
Journal: European Urology (2024)
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old
Authors: K. Numakura, M. Kobayashi, S. Hatakeyama, Y. Muto, Y. Sekine, R. Sobu, H. Sasagawa, H. Akashi, S. Kashima, R. Yamamoto, T. Nara, M. Saito, S. Narita, C. Ohyama, T. Habuchi
Journal: European Urology (2024)
Identifying the optimal definition of PSA response after metastasis directed therapy in men with oligo-recurrent prostate cancer detected at PSMA PET
Authors: E. Mazzone, G. Gandaglia, F. Pellegrino, A. Stabile, S. Scuderi, F. Barletta, D. Cannoletta, D. Robesti, A. Pellegrino, M. Longoni, P. Scilipoti, A.M. Samanes Gajate, M. Picchio, A. Chiti, S. Ghezzo, P. Mapelli, A. Necchi, D. Raggi, P.I. Karakiewicz, F. Montorsi, A. Briganti
Journal: European Urology (2024)
Efficacy and safety of fixed dose combination of silodosin and tadalafil in Indian patients with benign prostatic hyperplasia and erectile dysfunction: A phase 3 randomized clinical study
Authors: T.S. Avinash, P. Mondal, R. Chander, T. Mandal, J. Malviya, H. Chaudhari, P. Darakh, D. Patel, V. Singh, V. Kumar, R. Yadav, G. Andankar, H. Shah, P. Jindal, S. Patil, S. Das, M. Rajurkar, S. Saha, D. Patil, P. Patel, P. Ghadge, L. Lakhwani, S. Mehta, S. Joglekar
Journal: European Urology (2024)
Negative fusion biopsy in PIRADS 3-5 cases: What comes next in real world clinical practice?
Authors: R.S. Flammia, F. Proietti, G. Chiacchio, S. D’Annunzio, L. Misuraca, A. Brassetti, A.M. Bove, M.C. Ferriero, A. Minore, S. Basile, U. Anceschi, G. Tuderti, R. Mastroianni, S. Guaglianone, M.B. Sequi, Y. Al Salhi, C. Leonardo, F.M. Valenzi, A. Carbone, A. Pastore, G. Simone
Journal: European Urology (2024)
The association of county-level prostate-specific antigen screening with metastatic prostate cancer and prostate cancer mortality
Authors: D. Stelzl, B.V. Stone, M. Labban, E. Beatrici, D.K. Filipas, A.V. D’Amico, S.R. Lipsitz, T.K. Choueiri, A.S. Kibel, A.P. Cole, H.S. Iyer, Q-D. Trinh
Journal: European Urology (2024)
Tri-layer ureteral stents offer improved comfort: Results from an international prospective study
Authors: B.H. Chew, C.M. Forbes, K.F.V. Wong, R. Ren, A. Glaser, K. Taguchi, O. Shah, E. Tariel, C. Amarasekera, S. Hamamoto, W.R. Molina, J.J. Knoedler, A.E. Krambeck, M.E. Rivera, K.L. Stern, M.R. Humphreys
Journal: European Urology (2024)
STONE (STent Or NEphrostomy) study: Patient-reported outcome measures
Authors: H.W. Schuil, N. Hendriks, G.M. Kamphuis, B.C.H. Oskam, T.J.H. Arends, D. Duijvesz, B. Van Der Heij, I. Tjiam, W.A. Scheepens, F.C.H. d’Ancona, J.I.M. Van Uhm, J.H. Van Roijen, S. Weltings, R.W. Van Der Meer, J.E. Bosmans, R.C.M. Pelger, H.P. Beerlage, R.G. Duijnhoven, B.M.A. Schout
Journal: European Urology (2024)
The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment
Authors: F. Pellegrino, U.G. Falagario, A. Abbadi, L. Björnebo, A. Valdman, G. Carrieri, A. Briganti, F. Montorsi, O. Akre, M. Aly, M. Eklund, T. Nordström, H. Grönberg, A. Lantz, P. Wiklund
Journal: European Urology (2024)
WUTSUP-02-II-Neo-Dis-Tis: Investigating the efficacy and safety of neoadjuvant tislelizumab plus disitamab vedotin with adjuvant tislelizumab in upper urinary tract carcinoma - a phase II multi-center study
Authors: Y. Bao, X. Liao, P. Zhang, H. Zeng, J. Liu, Q. Wei
Journal: European Urology (2024)
Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer
Authors: L. Roma, I. Bratic Hench, F. Conticelli, L. Bubendorf, B. Calgua, C. Le Magnen, S. Piscuoglio, M. Rubin, A. Chirindel, G.P. Nicolas, T. Vlajnic, T. Zellweger, A.J. Templeton, F. Stenner, C. Ruiz, C. Rentsch, L. Bubendorf
Journal: European Urology (2024)
Patient derived renal cell carcinoma organoids and isolated autologous tumor infiltrating lymphocytes as cancer in vitro models for immunotherapy agents screening
Authors: V. Hevia Palacios, J. García-Donas, E. García-Rojo, J.F. Rodriguez-Moreno, J. Feltes, E. Sevillano, G. Duque, T. Grazioso, R. Brime, A. Barquin, M. Quiralte, J. Romero, P. Navarro
Journal: European Urology (2024)
Predictive factors for failure of surgical treatment of vesicovaginal fistulas
Authors: K. Chaker, Y. Ouanes, M. Marrak, N. Gharbia, B. Mosbahi, H. Fakhfakh, A. Hariz, O. Chbeb, M. Bibi, K. Mrad Dali, M. Rahoui, K. Abid, A. Ammous, Y. Nouira
Journal: European Urology (2024)
How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series
Authors: A. Pellegrino, A. Stabile, L. Quarta, F. Barletta, E. Mazzone, D. Cannoletta, F. Pellegrino, G. Sorce, V. Cucchiara, S. Scuderi, D. Robesti, R. Leni, G.O. Cirulli, M. Longoni, P. Scilipoti, M. De Angelis, F. De Cobelli, A. Esposito, G. Gandaglia, F. Montorsi, A. Briganti
Journal: European Urology (2024)
Loss of glucocorticoid receptor expression in diagnostic biopsies of metastatic prostate cancer is associated with poor response to sequential docetaxel treatment
Authors: J.M. Moll, L. Mout, C.F. Kweldam, M. Wissing, E.M. de Morrée, G.J.L.H. Van Leenders, G.W. Jenster, W.M. Van Weerden
Journal: European Urology (2024)
Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p/FBXW7/HSF1 axis under hypoxic microenvironment
Authors: Z. Liu, Z. Lin, M. Jiang, G. Zhu, T. Xiong, F. Cao, Y. Cui, Y. Niu
Journal: European Urology (2024)
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients
Authors: N. Mookerji, T. Pfanner, A. Hui, G. Huang, S. Broomfield, L. Dean, B. Adam, P. Dromparis, P. Albers, C. Fung, A. Tamm, A. Kinnaird
Journal: European Urology (2024)
Diagnostic accuracy of liquid biomarkers for clinically significant prostate cancer detection: A systematic review and diagnostic meta-analysis of multiple thresholds
Authors: T. Kawada, S.R. Shim, F. Quhal, P. Rajwa, B. Pradere, T. Yanagisawa, K. Bekku, E. Laukhtina, M. Von Deimling, M. Araki, F.S. Shahrokh
Journal: European Urology (2024)
Are reference intervals for free testosterone in healthy men reliable also in men with erectile dysfunction? Findings from a cross-sectional study
Authors: L. Boeri, E. Pozzi, F. Belladelli, A. Bertini, C. Corsini, M. Raffo, F. Negri, M. Oddo, L. Candela, G. Fallara, P. Capogrosso, L. Zahiti, A. Mattei, F. Dehò, E. Montanari, A. d’Arma, F. Montorsi, A. Salonia
Journal: European Urology (2024)
Predictors of renal function improvement after partial nephrectomy
Authors: J. Afari, C. Saitta, K.L. Yuen, D. Puri, M.V. Nguyen, M. Meagher, L. Wang, K.H. Kevin, J. Roberts, F. Liu, E. Nicaise, R. Greenwald, N. Imtiaz, D. Patil, Y. Fujii, I.H. Derweesh
Journal: European Urology (2024)
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium
Authors: Y. Tohi, J.M. Sahrmann, J. Arbet, T. Kato, L.S. Lee, M. Peacock, K. Ginsburg, C. Pavlovich, P. Carroll, C.H. Bangma, M. Sugimoto, P.C. Boutros
Journal: European Urology (2024)
Surgical experience and functional outcomes after laparoscopic and robot-assisted partial nephrectomy: Results from a multi-institutional collaboration
Authors: C.A. Bravi, S. Tappero, P. Dell’Oglio, R. Campi, R. Bertolo, L.F. Da Pozzo, G. Simone, N. Suardi, R. Schiavina, K. Bensalah, E. Canda, X. Zhang, C. Terrone, S. Shariat, F. Porpiglia, A. Antonelli, J. Kaouk, K. Badani, A. Minervini, I. Derweesh, A. Breda, A. Mottrie, F. Montorsi, A. Larcher
Journal: European Urology (2024)